Neurotoxicity due to adenine arabinoside therapy during varicella-zoster virus infections in immunocompromised children.
D000293:Adolescent; D016026:Bone Marrow Transplantation; D002644:Chickenpox / Q000150:complications / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007108:Immune Tolerance; D009369:Neoplasms / Q000150:complications; D014740:Vidarabine / Q000009:adverse effects* / Q000627:therapeutic use
D014740:Vidarabine